Vanguard Group’s CARDIUM THERAPEUTICS INC NEW CXM Stock Holding History

Vanguard Group’s Portfolio CXM Stock Details CXM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-15,324	Closed	-$13K	–	4004
2013 Q4	$13K	Hold	15,324	–	–	﹤0.01%	3897
2013 Q3	$17K	Sell	15,324 -71,230	-82%	-$72.3K	﹤0.01%	3832
2013 Q2	$121K	Buy	+86,554	New	+$156K	﹤0.01%	3710

Vanguard Group's CXM Position: Q1 2014 in Review

Vanguard Group sold out of CARDIUM THERAPEUTICS INC NEW (CXM) in Q1 2014, closing a stake of 15,324 shares — an estimated $13K sold.

Vanguard Group first reported a position in CXM in Q2 2013 and held it in 3 quarters. The position peaked at $121K in Q2 2013. 0 funds tracked by Wall St. Rank hold CXM as of Q1 2014.

Vanguard Group reported no remaining CARDIUM THERAPEUTICS INC NEW position as of Q1 2014 after selling out during the quarter.
Vanguard Group sold 15,324 CARDIUM THERAPEUTICS INC NEW shares in Q1 2014, an estimated $13K.
Vanguard Group first reported a position in CARDIUM THERAPEUTICS INC NEW in Q2 2013 and held it in 3 quarters.
Vanguard Group's CARDIUM THERAPEUTICS INC NEW position peaked at $121K in Q2 2013.
0 funds tracked by Wall St. Rank held CARDIUM THERAPEUTICS INC NEW as of Q1 2014.

Based on Vanguard Group's 13F filing for Q1 2014, filed 13 May 2014.